慢性病流行病学，尤其是肿瘤的流行病学研究，重点是肿瘤筛查和早诊早治以及队列研究等。

全国十大赌博官网

1. Li N#, Tan F#, Chen W#, Dai M#, Wang F, Shen S, Tang W, Li J, Yu Y, Cao W, Xu Y, Qin C, Zhao L, Zhu M, Guo L, Wu Z, Yang Z, Zheng Y, Chen H, Liu Y, Wei D, Dong D, Cao J, Zhang S, Yan S, Wang N, Du L, Shen H, Wu N, He J*, National Lung Cancer Screening programme group. One-off low-dose CT for lung cancer screening in China: A multicentre, population-based, prospective cohort study. Lancet Respir Med. 2022, 10(4):378-391. (IF=102.642)

2. Chen H#, Shi J#, Lu M, Li Y, Du L, Liao X, Wei D, Dong D, Gao Y, Zhu C, Ying R, Zheng W, Yan S, Xiao H, Zhang J, Kong Y, Li F, Zou S, Liu C, Wang H, Zhang Y, Lu B, Luo C, Cai J, Tian J, Miao X, Ding K, Brenner H, Dai M*. Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C). Clin Gastroenterol Hepatol. 2022, S1542-3565(22)00767-4. Online ahead of print. (IF=13.576)

3. Zhang Y#, Chen H*, Lu M, Cai J, Lu B, Luo C, Dai M*. Habitual Diet Pattern Associations with Gut Microbiome Diversity and Composition: Results from a Chinese Adult Cohort. Nutrients. 2022, 14(13):2639. (IF=6.706)

4. Cai J#, Chen H#, Lu M, Zhang Y, Lu B, You L, Zhang T, Dai M*, Zhao Y*. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021, 520:1-11. (IF=9.756)

5. Shi J#, Wang L, Ran J, Wang H, Liu C, Zhang H, Yang L, Shi S, Jiang L, Fan J, Zhang Y, Wang W, Ren J, Zhu L, Zheng Z, Sun Y, Zou S, Jiang J, Chen B, Chen H, Liu G, Yang L, Huang Y, Guo LW, Wang D, Zhang Y, Mao A, Wang J, Gong J, Wei D, Qiu W, Song B, Zhang K, Li N, Feletto E, Lew J, Qiao Y, Chen W*, Dai M*, He J*. Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey. Cancer. 2021, 127(11):1880-1893. (IF=6.860)

6. Lu M#, Wang L, Zhang Y, Liu C, Lu B, Du L, Liao X, Dong D, Wei D, Gao Y, Shi J, Ren J, Chen H*, Dai M*. Optimizing positivity thresholds for a risk-adapted screening strategy in colorectal cancer screening. Clin Transl Gastroenterol. 2021, 12(8):e00398. (IF=4.396, R)

7. Chen H#, Lu M, Liu C, Zou S, Du L, Liao X, Dong D, Wei D, Gao Y, Zhu C, Zhu L, Zheng W, Xiao H, Kong Y, Yin H, Zhou H, Ying R, Wang B, Zhang J, Zhang X, Zhang Q, Zhang X, Zhang Y, Wang H, Guo L, Liu L, Ren J, Shi J, Li N, Miao X, Brenner H, Dai M*. Comparative evaluation of participation and diagnostic yield of colonoscopy vs fecal immunochemical test vs risk-adapted screening in colorectal cancer screening: interim analysis of a multicenter randomized controlled trial (TARGET-C). Am J Gastroenterol. 2020, 115(8):1264-1274. (IF=10.864, R)

8. Shi J#, Liu C, Ren J, Parascandola M, Zheng R, Tang W, Huang H, Li F, Wang L, Su K, Li N, Zhang K, Chen W, Wu N, Zou X, Liu G, Dai M*. Economic burden of lung cancer attributable to smoking in China in 2015. Tob Control. 2020, 29(2):191-199. (IF=7.522)

9. Feng X#, Wang G, Lyu Z, Chen S, Wei L, Li X, Wen Y, Chen Y, Xie S, Cui H, Chen H, Li J, Lin C, Ren J, Shi J, Wu S, Dai M*, Li N*, He J*. The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes. Int J Cancer. 2020, 147(4):958-966. (IF=7.396)

10. Chen H#, Li N#, Ren J, Feng X, Lyu Z, Wei L, Li X, Guo L, Zheng Z, Zou S, Zhang Y, Li J, Zhang K, Chen W, Dai M*, He J*; group of Cancer Screening Program in Urban China (CanSPUC). Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019, 68(8):1450-1457. (IF=19.819)